首页> 外文期刊>European Journal of Pharmacology: An International Journal >A K(ATP) channel opener inhibited myocardial reperfusion action potential shortening and arrhythmias.
【24h】

A K(ATP) channel opener inhibited myocardial reperfusion action potential shortening and arrhythmias.

机译:K(ATP)通道开放剂抑制心肌再灌注动作电位的缩短和心律不齐。

获取原文
获取原文并翻译 | 示例
           

摘要

Low concentrations of certain K(ATP) channel openers have been reported to exert a moderate inhibitory effect on arrhythmias during post-ischaemic early myocardial reperfusion, but the accompanying effects on the time course of changes in action potentials in intact hearts have not yet been studied. We report that in rat isolated hearts, reperfusion following 10 min of regional no-flow ischaemia was associated with both an acute, marked, but transient, shortening of ventricular repolarisation (by 63%) during reperfusion, and a high incidence (90%) of ventricular tachyarrhythmias. The K(ATP) channel opener Ro 31-6930 [2-(6-cyano-2,2-dimethyl-2H-1-benzopyran-4-yl)-pyridine 1-oxide], delivered prior to ischaemia at a relatively low concentration (0.5 microM), significantly reduced the incidence and duration of reperfusion arrhythmias, and prevented the associated acute action potential shortening during reperfusion, each in a glibenclamide (1 microM)-sensitive manner (P<0.05, n=10-15 hearts). This was associated with a moderate and non-arrhythmogenic action potential shortening during ischaemia (a potentially "cardioprotective" effect). However, these data highlight the potential harm these drugs may cause, since a higher concentration of Ro 31-6930 caused marked shortening of action potentials and significant pro-arrhythmia during ischaemia.
机译:据报道,低浓度的某些K(ATP)通道开放剂在缺血后早期心肌再灌注过程中对心律不齐具有中等抑制作用,但尚未研究完整心脏中动作电位变化随时间变化的伴随作用。 。我们报道在大鼠离体心脏中,局部无血流局部缺血10分钟后的再灌注与再灌注过程中急性的,明显的但短暂的心室复极缩短(63%)和高发生率(90%)有关。室性快速性心律失常。 K(ATP)通道开放剂Ro 31-6930 [2-(6-氰基-2,2-二甲基-2H-1-苯并吡喃-4-基)-吡啶1-氧化物],在缺血前以相对较低的浓度递送浓度(0.5 microM),显着降低了再灌注性心律失常的发生率和持续时间,并防止了再灌注过程中相关的急性动作电位缩短,每种方式均对glibenclamide(1 microM)敏感(P <0.05,n = 10-15心) 。这与缺血期间中度和非心律失常的动作电位缩短有关(可能是“心脏保护”作用)。但是,这些数据突显了这些药物可能造成的潜在危害,因为较高的Ro 31-6930浓度会导致局部缺血期间动作电位明显缩短,并导致明显的心律失常。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号